Saturday, September 22, 2018
This year marks the 10th anniversary of the launch of Stand Up To Cancer (SU2C)—an enterprise that was at its inception an innovative and somewhat radical concept in cancer research: creating collaborative dream teams of researchers from various disciplines...
Infection with human papillomavirus (HPV) can cause certain cancers in women and men, but HPV vaccines are highly effective in preventing infection with oncogenic HPV types. A new British Journal of Clinical Pharmacology review of post-licensure data did not...
Details of the initial data from an ongoing investigator-sponsored Phase II clinical trial in which investigators are evaluating DPX-Survivac, a drug being developed by IMV, in combination with low dose cyclophosphamide and Merck’s checkpoint inhibitor pembrolizumab (Keytruda®) in patients...
Study results published in Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR) shows that hispanic pediatric patients are more likely than non-Hispanic whites to develop neurotoxicity during the course of methotrexate chemotherapy for acute...
Every day cancer kills nearly 1,900 people in the United States and Canada alone. This is, on average, more than one person every minute. And while there are many new and better diagnostic and treatment options today than a...
Scientists at Cedars-Sinai, a non-profit, tertiary 958-bed hospital and multi-specialty academic health science center located in the Beverly Grove neighborhood of Los Angeles, California, have discovered how prostate cancer can sometimes withstand and even outwit a standard hormone therapy. ...
Each year, about 1.7 million Americans are diagnosed with cancer, and about 600,000 die from cancer. Fortunately, there are now over 16 million cancer survivors in the U.S. We know that pain is an issue for cancer patients, especially...
Earlier this year, thirteen years after losing her mother to glioblastoma, Manon Rinsma-Leonard, MSc*, found the inner strength to share her personal, heartbreaking, experience with the world. "13 Diamonds – Life Before Death from a Child’s Perspective", the book...
In an article published in Cancer Discovery, a journal of the American Association for Cancer Research (AACR) Co-senior authors Andrea Sottoriva, PhD, MSc, Chris Rokos Fellow in Evolution and Cancer and team leader at The Institute of Cancer Research,...
Rintatolimod (Ampligen®; Hemispherx Biopharma) is a mismatched, double-stranded RNA molecule with immunomodulatory and antiviral properties. The drug acts as a Toll-like Receptor 3 (TLR3) agonists. TLR3s have been extensively used as adjuvants for anticancer vaccines. Rintatolimod stimulates the production...

Related articles